Research Article
Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway
Figure 2
Bardoxolone methyl reduces the myocardial infarct size and decreases pathological changes in cardiomyocytes. (a) Triphenyltetrazolium chloride staining (TTC; ), (b) H&E staining, and (c) Masson staining. Magnification of microscope: ×200. Scale bar: 100 μm. .
(a) |
(b) |
(c) |